Exploring the clinical pharmacology of the nonnucleoside reverse transcriptase inhibitors

Exploring the clinical pharmacology of the nonnucleoside reverse transcriptase inhibitors

Bibliographic Details
Main Author:	Almond, Lisa
Published:	University of Liverpool 2004
Subjects:	616.97920610724
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.405060

Similar Items

The intracellular pharmacology of the antiretroviral protease inhibitors in a clinical setting
by: Ford, Jennifer
Published: (2004)

Methodological quality of randomized controlled trials of HIV/AIDS interventions, with special reference to trials conducted in Africa
by: Siegfried, Nandi Louise
Published: (2007)

Dextrin sulphate possesses characteristics of a microbicide capable of blocking HIV-1 transmission in-vivo
by: Low-Beer, Naomi
Published: (2003)

Binding of the Nonnucleoside Reverse Transcriptase Inhibitor Efavirenz to HIV-1 Reverse Transcriptase Monomers and Dimers
by: Braz, Valerie Ann
Published: (2009)

Binding of the Nonnucleoside Reverse Transcriptase Inhibitor Efavirenz to HIV-1 Reverse Transcriptase Monomers and Dimers
by: Braz, Valerie Ann
Published: (2010)

Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.
by: Anna Figueiredo, et al.
Published: (2006-11-01)

Assessment of Nonnucleoside Inhibitors Binding to HIV-1 Reverse Transcriptase Using HYDE Scoring
by: Agata Paneth, et al.
Published: (2019-04-01)

Review The Emerging Profile of Cross-Resistance among the Nonnucleoside HIV-1 Reverse Transcriptase Inhibitors
by: Nicolas Sluis-Cremer
Published: (2014-07-01)

Pharmacokinetics and tolerability of the new second-generation nonnucleoside reverse- transcriptase inhibitor KM-023 in healthy subjects
by: Cha YJ, et al.
Published: (2014-09-01)

The role of Gag in HIV-1 DNA synthesis and sensitivity to reverse transcriptase inhibitor drugs
by: Kerridge, Claire Jane
Published: (2018)

Mitochondrial toxicity of nucleoside reverse transcriptase inhibitors in a rat phaeochromocytoma cell line
by: Clarke, Anna B.
Published: (2006)

Efficacy of nucleoside reverse transcriptase inhibitors on a HIV-1 infected human brain aggregate model
by: Kandanearatchi, Apsara Lakmini
Published: (2003)

Natural presence of the V179D and K103R/V179D mutations associated with resistance to nonnucleoside reverse transcriptase inhibitors in HIV-1 CRF65_cpx strains
by: Yongjian Liu, et al.
Published: (2020-04-01)

Structural mechanisms of drug resistance for HIV reverse transcriptases
by: Chamberlain, Philip Paul
Published: (2004)

Studies on clinical and epidemiological factors associated with peripheral neuropathy and severe hyperlactatemia or lactic acidosis in HIV-infected adults exposed to nucleoside analogues reverse transcriptase inhibitors
by: Rafael Arenas-Pinto, A.
Published: (2007)

Discovery of nonnucleoside inhibitors of polymerase from infectious pancreatic necrosis virus (IPNV)
by: Bello-Pérez M, et al.
Published: (2018-07-01)

Reverse transcriptase activity in psoriatic lesions: effects of reverse transcriptase inhibitors on keratinocyte proliferation and differentiation
by: Bonté Frédéric, et al.
Published: (2009-09-01)

The role of the HIV-1 reverse transcriptase mutation H208Y to drug resistance and viral fitness
by: Malik, S.
Published: (2011)

Techniques for the investigation of the relative fitnesses of Human Immunodeficiency Virus type 1 reverse transcriptase domains
by: Bibby, David Frank
Published: (2002)

Intracellular phosphorylation of nucleoside reverse transcriptase inhibitors
by: Sales, Sean Douglas
Published: (2000)

The t(4;11) fusion protein MLL/AF4 regulates telomerase reverse transcriptase (TERT) expression
by: Greßner, Andreas
Published: (2011)

Clinical pharmacology of human immunodeficiency virus-1 protease inhibitors
by: Boffito, Marta
Published: (2004)

Exploring QSAR of Non-Nucleoside Reverse Transcriptase Inhibitors by Neural Networks: TIBO Derivatives
by: Driss Cherqaoui, et al.
Published: (2004-01-01)

Exploring QSAR of non-nucleoside reverse transcriptase inhibitors by artificial neural networks: HEPT derivatives
by: Mohamed Zahouily, et al.
Published: (2007-09-01)

Population and single genome kinetics driving the evolution of multiple linked multiclass drug resistance mutations in the viral protease and reverse transcriptase of HIV-1 subtype C in children receiving early protease inhibitor based combination therapy
by: Lange, C. M.
Published: (2015)

In vitro and in vivo effects of human dendritic cells generated using a novel combination of cytokines and pulsed with nonapeptides of human telomerase reverse transcriptase
by: Mckechnie, Alasdair John
Published: (2006)

Non-Nucleoside Reverse Transcriptase Inhibitors Join Forces with Integrase Inhibitors to Combat HIV
by: Daniel M. Himmel, et al.
Published: (2020-06-01)

Lipidic strategy for improving bioavailability of nucleoside HIV reverse transcriptase inhibitor
by: N. S. Shastina, et al.
Published: (2011-04-01)

Reverse Transcriptase Inhibitors Nanosystems Designed for Drug Stability and Controlled Delivery
by: Fedora Grande, et al.
Published: (2019-04-01)

Inhibitors of HIV-1 Reverse Transcriptase—Associated Ribonuclease H Activity
by: Michael A. Parniak, et al.
Published: (2012-10-01)

Development of triazine non-nucleoside reverse transcriptase inhibitors for microbicidal applications
by: Lewi Paul, et al.
Published: (2011-10-01)

Focus on Chirality of HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors
by: Valeria Famiglini, et al.
Published: (2016-02-01)

Biological evaluation of inhibitors of reverse transcriptase from HIV type-1
by: Hitendra Kumar Lautre, et al.
Published: (2015-01-01)

Isatin thiazoline hybrids as dual inhibitors of HIV-1 reverse transcriptase
by: Rita Meleddu, et al.
Published: (2017-01-01)

Structure-based design of novel inhibitors of HIV-1 reverse transcriptase
by: Hopkins, Andrew Lee
Published: (1998)

Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naïve HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
by: Pei-Ying Wu, et al.
Published: (2017-01-01)

Dolutegravir Plus Two Nucleoside Reverse Transcriptase Inhibitors versus Efavirenz Plus Two Nucleoside Reverse Transcriptase Inhibitors As Initial Antiretroviral Therapy for People with HIV: A Systematic Review.
by: George W Rutherford, et al.
Published: (2016-01-01)

A reverse transcriptase ribozyme
by: Biswajit Samanta, et al.
Published: (2017-09-01)

TELOMERASE REVERSE TRANSCRIPTASE IN ATHEROSCLEROSIS
by: Qing, Hua
Published: (2017)

The structure of FIV reverse transcriptase and its implications for non-nucleoside inhibitor resistance.
by: Meytal Galilee, et al.
Published: (2018-01-01)